NCT02112500View on ClinicalTrials.gov

Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure

PHASE2UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Respiratory Distress Syndrome, Adult
Interventions
BIOLOGICAL

Mesenchymal Stem Cell

Mesenchymal stem cells will be intravenously infused. Mesenchymal stem cells will be cultured and extracted from the bone marrow of the patients.

Trial Locations (1)

138-736

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER